Tagomic
Biotechnology company harnessing the power of multiomics to transform genomic medicine, integrating multiple types of biological data to enable more comprehensive understanding of disease and treatment.
Website
https://www.tagomic.comLocation
Boston, Massachusetts, USA
Founded
2021
Investors
1
Categories
multiomics, genomic-medicine, biotech, diagnostics, precision-medicine
Notes
Tagomic is a biotechnology company harnessing the power of multiomics to transform genomic medicine. The company integrates multiple types of biological data - including genomics, transcriptomics, proteomics, and metabolomics - to enable a more comprehensive understanding of disease biology and treatment response.
Multiomics approaches provide a more complete picture of biological systems than single-omic methods, enabling:
- Better disease characterization
- Improved patient stratification
- More accurate treatment selection
- Novel biomarker discovery
Tagomic's platform aims to translate multiomics insights into clinical applications that improve patient outcomes.
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Multiomics integration platform
- Genomic medicine applications
- Precision medicine focus
- Disease characterization capabilities
- Boston, Massachusetts headquarters
- Founded in 2021
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Illumina Ventures | San Francisco, California, USA | biotech-focused | seedseries-a+1 | 32 |